-
1
-
-
84922169860
-
Carbapenemase-producing enterobacteriaceae
-
Doi Y, Paterson DL. 2015. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 36:74 – 84. https://doi.org/10.1055/s-0035-1544208.
-
(2015)
Semin Respir Crit Care Med
, vol.36
, pp. 74 - 84
-
-
Doi, Y.1
Paterson, D.L.2
-
2
-
-
85011032488
-
Molecular epidemiology of carbapenemase-producing enterobacteriaceae in a primary care hospital in japan, 2010-2013
-
Ohno Y, Nakamura A, Hashimoto E, Matsutani H, Abe N, Fukuda S, Hisashi K, Komatsu M, Nakamura F. 2017. Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013. J Infect Chemother 23:224 –229. https://doi.org/10.1016/j.jiac.2016.12.013.
-
(2017)
J Infect Chemother
, vol.23
, pp. 224 -229
-
-
Ohno, Y.1
Nakamura, A.2
Hashimoto, E.3
Matsutani, H.4
Abe, N.5
Fukuda, S.6
Hisashi, K.7
Komatsu, M.8
Nakamura, F.9
-
3
-
-
83055176346
-
IMP-6
-
IMP-6. Diagn Microbiol Infect Dis 72:109–112. https://doi.org/10.1016/j.diagmicrobio.2011.09.019.
-
(2012)
Diagn Microbiol Infect Dis
, vol.72
, pp. 109-112
-
-
Shigemoto, N.1
Kuwahara, R.2
Kayama, S.3
Shimizu, W.4
Onodera, M.5
Yokozaki, M.6
Hisatsune, J.7
Kato, F.8
Ohge, H.9
Sugai, M.10
-
4
-
-
83955163604
-
Rapid detection of blaimp-6 by amplification refractory mutation system
-
IMP-6 by amplification refractory mutation system. J Microbiol Methods 88: 182–184. https://doi.org/10.1016/j.mimet.2011.10.022.
-
(2012)
J Microbiol Methods
, vol.88
, pp. 182-184
-
-
Kayama, S.1
Shigemoto, N.2
Kuwahara, R.3
Onodera, M.4
Yokozaki, M.5
Ohge, H.6
Kato, F.7
Hisatsune, J.8
Sugai, M.9
-
5
-
-
84869209792
-
The sequence-activity relationship between metallo-β-lactamases imp-1, imp-6, and imp-25 suggests an evolutionary adaptation to meropenem exposure
-
Liu EM, Pegg KM, Oelschlaeger P. 2012. The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposure. Antimicrob Agents Chemother 56:6403–6406. https://doi.org/10.1128/AAC.01440-12.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 6403-6406
-
-
Liu, E.M.1
Pegg, K.M.2
Oelschlaeger, P.3
-
6
-
-
84930974446
-
Mechanism of resistance and antibacterial susceptibility in esbl-phenotype klebsiella pneumoniae and klebsiella oxytoca isolated between 2000 and 2010 in japan
-
Sato T, Hara T, Horiyama T, Kanazawa S, Yamaguchi T, Maki H. 2015. Mechanism of resistance and antibacterial susceptibility in ESBL-phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan. J Med Microbiol 64:538–543. https://doi.org/10.1099/jmm.0.000057.
-
(2015)
J Med Microbiol
, vol.64
, pp. 538-543
-
-
Sato, T.1
Hara, T.2
Horiyama, T.3
Kanazawa, S.4
Yamaguchi, T.5
Maki, H.6
-
7
-
-
84939972340
-
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—9th ed
-
Clinical and Laboratory Standards Institute. Clinical and Laboratory Standards Institute, Wayne, PA
-
Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—9th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
-
(2012)
CLSI Document M07-A9
-
-
-
8
-
-
33646696219
-
-
Clinical and Laboratory Standards Institute. 26th ed. CLSI supplement M100S. Clinical and Laboratory Standards Institute, Wayne, PA
-
Clinical and Laboratory Standards Institute. 2016. Performance standards for antimicrobial susceptibility testing, 26th ed. CLSI supplement M100S. Clinical and Laboratory Standards Institute, Wayne, PA.
-
(2016)
Performance Standards for Antimicrobial Susceptibility Testing
-
-
-
9
-
-
84996478385
-
Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against pseudomonas aeruginosa
-
Ito A, Nishikawa T, Matsumoto S, Yoshizawa H, Sato T, Nakamura R, Tsuji M, Yamano Y. 2016. Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 60:7396–7401. https://doi.org/10.1128/AAC.01405-16.
-
(2016)
Antimicrob Agents Chemother
, vol.60
, pp. 7396-7401
-
-
Ito, A.1
Nishikawa, T.2
Matsumoto, S.3
Yoshizawa, H.4
Sato, T.5
Nakamura, R.6
Tsuji, M.7
Yamano, Y.8
-
10
-
-
84954494697
-
In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing gram-negative bacilli
-
Vasoo S, Cunningham SA, Cole NC, Kohner PC, Menon SR, Krause KM, Harris KA, De PP, Koh TH, Patel R. 2015. In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing gram-negative bacilli. Antimicrob Agents Chemother 59:7842–7846. https://doi.org/10.1128/AAC.02019-15.
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 7842-7846
-
-
Vasoo, S.1
Cunningham, S.A.2
Cole, N.C.3
Kohner, P.C.4
Menon, S.R.5
Krause, K.M.6
Harris, K.A.7
De, P.P.8
Koh, T.H.9
Patel, R.10
-
11
-
-
0027957461
-
Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of serratia marcescens that shows imipenem resistance
-
Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yo-shimura F, Kato N. 1994. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38:71–78. https://doi.org/10.1128/AAC.38.1.71.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 71-78
-
-
Osano, E.1
Arakawa, Y.2
Wacharotayankun, R.3
Ohta, M.4
Horii, T.5
Ito, H.6
Yo-shimura, F.7
Kato, N.8
-
12
-
-
84977110010
-
Stability of novel siderophore cephalosporin s-649266 against clinically relevant carbapenemases
-
Ito-Horiyama T, Ishii Y, Ito A, Sato T, Nakamura R, Fukuhara N, Tsuji M, Yamano Y, Yamaguchi K, Tateda K. 2016. Stability of novel siderophore cephalosporin S-649266 against clinically relevant carbapenemases. Antimicrob Agents Chemother 60:4384 – 4386. https://doi.org/10.1128/AAC.03098-15.
-
(2016)
Antimicrob Agents Chemother
, vol.60
, pp. 4384 - 4386
-
-
Ito-Horiyama, T.1
Ishii, Y.2
Ito, A.3
Sato, T.4
Nakamura, R.5
Fukuhara, N.6
Tsuji, M.7
Yamano, Y.8
Yamaguchi, K.9
Tateda, K.10
-
13
-
-
84947492691
-
The safety of polymyxin antibiotics
-
Kelesidis T, Falagas ME. 2015. The safety of polymyxin antibiotics. Expert Opin Drug Saf 14:1687–1701. https://doi.org/10.1517/14740338.2015.1088520.
-
(2015)
Expert Opin Drug Saf
, vol.14
, pp. 1687-1701
-
-
Kelesidis, T.1
Falagas, M.E.2
-
14
-
-
84876741206
-
Aminoglycosides in septic shock
-
Boyer A, Gruson D, Bouchet S, Clouzeau B, Hoang-Nam B, Vargas F, Gilles H, Molimard M, Rogues A, Moore N. 2013. Aminoglycosides in septic shock. Drug Saf 36:217–230. https://doi.org/10.1007/s40264-013-0031-0.
-
(2013)
Drug Saf
, vol.36
, pp. 217-230
-
-
Boyer, A.1
Gruson, D.2
Bouchet, S.3
Clouzeau, B.4
Hoang-Nam, B.5
Vargas, F.6
Gilles, H.7
Molimard, M.8
Rogues, A.9
Moore, N.10
|